Trademark: 79203384
Word
KIOMED
Status
Registered
Status Code
700
Status Date
Tuesday, March 13, 2018
Serial Number
79203384
Registration Number
5420385
Registration Date
Tuesday, March 13, 2018
Mark Type
5000
Filing Date
Thursday, September 29, 2016
Published for Opposition
Tuesday, December 26, 2017

Trademark Owner History
KiOmed Pharma, Société Anonyme - Original Registrant

Classifications
5 Pharmaceutical preparations for the treatment and prevention of musculo-sketletal disorders, dermal volumizing and dermatological disorders, eye disorder or eye tissue regeneration, acute and chronic diseases by achieving sustained and targeted delivery of the active, locally, intravenously or orally; veterinary preparations for the treatment and prevention of musculo-sketletal disorders, dermal volumizing and dermatological disorders, eye disorder or eye tissue regeneration, acute and chronic diseases by achieving sustained and targeted delivery of the active, locally, intravenously or orally in farm animals and domestic pets; sanitary products for medical purposes; dietetic food and substances, namely, wheat-free and gluten-free pasta, crakers, bread to accommodate special medical and health conditions, dietetic sugar and infusion adapted for medical or veterinary use; materials for medical dressings; material for dental fillings and dental impressions; disinfectants for hygienic purposes, disinfectants for sanitary purposes, disinfectants for medical instruments; bath preparations for medical use; chemical preparations for medical or pharmaceutical use for the treatment and prevention of musculoskeletal disorders, dermal volumizing and dermatological disorders, eye disorder or eye tissue regeneration, acute and chronic diseases by achieving sustained and targeted delivery of the active, locally, intravenously or orally; pharmaceutical products based on materials of plant origin for the treatment and prevention of musculoskeletal disorders, dermal volumizing and dermatological disorders, eye disorder or eye tissue regeneration, acute and chronic diseases by achieving sustained and targeted delivery of the active, locally, intravenously or orally; pharmaceutical products based on chitosan, chitin, chitosan derivatives of vegetable origin, chitin derivatives for the treatment and prevention of musculoskeletal disorders, dermal volumizing and dermatological disorders, eye disorder or eye tissue regeneration, acute and chronic diseases by achieving sustained and targeted delivery of the active, locally, intravenously or orally; vaccines; preparations for vaccines
1 Chemicals, namely, chitosan, chitin, chitosan derivatives; chemicals, namely, chitin derivatives; chemical products for use in industry or science; chemical additives for manufacture of pharmaceutical products, vaccines and cosmetics; active chemical ingredients used in the manufacture of pharmaceutical products for treating musculo-sketletal disorders, dermal volumizing and dermatological disorders, eye disorder or eye tissue regeneration, acute and chronic diseases by achieving sustained and targeted delivery of the active, locally, intravenously or orally
44 Medical services; veterinary services; hygienic and beauty care for human beings or animals; medical assistance; cosmetic surgery; hospital services; nursing homes; convalescence or rest homes; opticians' services; alternative medicine services; health counseling services; medical equipment rental; telemedicine services; therapeutic services, namely therapeutic radiological services
10 Surgical, medical, dental and veterinary apparatus and instruments, namely, vertebral osteosynthesis staple-shaped apparatus and instruments, devices used in orthopedic surgery to position surgical instruments, implants and/or patients' limbs, orthopedic fixation device used in orthopedic transplant and/or implant surgery, surgical and medical apparatus and instruments for use in spinal, general, orthopedic surgery; artificial limbs, eyes and teeth; orthopedic articles, namely orthopedic cushions and braces, suture material; bone, joint, hip and breast prostheses, staple-shaped prostheses for the spinal column, staple-shaped prostheses of vertebral discs; artificial implants, namely to fill joints and bones, to fill the dermis and other conjunctival tissues, artificial implants to be used as surgical aids
42 Scientific services, namely research, testing, analysis and development services in the fields of medicine, pharmaceutical products, chemistry, biochemistry, biology, biotechnology or bacteriology; design and development of medical technologies; conducting clinical trials and preliminary evaluations for others , particularly for pharmaceutical products; evaluation of pharmaceutical products; scientific research and development services relating to vaccines and medicines; scientific research, analysis and development services in chemistry, biochemistry, biology, biotechnology or bacteriology; scientific research, analysis and development services in cosmetology; basic scientific research and clinical research in the fields of science, namely clinical trials and medicine; scientific research, testing and development of products developed using materials of vegetable origin; scientific research, testing and development of products developed using chitosan, chitin, chitosan derivatives of vegetable origin, chitin derivatives; carrying out technical or scientific studies in the fields of medicine, pharmaceutical products, chemistry, biochemistry, biology, biotechnology or bacteriology; provision of information and a database relating to scientific and medical research and development in the field of pharmaceutical products, chemistry, biochemistry, biology, biotechnology or bacteriology
Color is not claimed as a feature of the mark.

Trademark Events
Mar 13, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Mar 7, 2019
New Representative At Ib Received
Jul 13, 2018
Final Decision Transaction Processed By Ib
Jun 19, 2018
Final Disposition Notice Sent To Ib
Jun 19, 2018
Final Disposition Processed
Jun 13, 2018
Final Disposition Notice Created, To Be Sent To Ib
Mar 13, 2018
Registered-Principal Register
Dec 26, 2017
Official Gazette Publication Confirmation E-Mailed
Dec 26, 2017
Published For Opposition
Dec 22, 2017
Notification Processed By Ib
Dec 6, 2017
Notification Of Possible Opposition Sent To Ib
Dec 6, 2017
Notification Of Notice Of Publication E-Mailed
Dec 6, 2017
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 9, 2017
Approved For Pub - Principal Register
Sep 22, 2017
Teas/Email Correspondence Entered
Sep 21, 2017
Correspondence Received In Law Office
Sep 21, 2017
Teas Response To Office Action Received
Apr 9, 2017
Refusal Processed By Ib
Mar 23, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Mar 23, 2017
Refusal Processed By Mpu
Mar 22, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Mar 21, 2017
Non-Final Action Written
Mar 21, 2017
Application Filing Receipt Mailed
Mar 17, 2017
Assigned To Examiner
Mar 17, 2017
New Application Office Supplied Data Entered
Mar 16, 2017
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24